The role of interleukin-17 in asthma: a protective response?
While there now exist effective treatments for type 2 high, eosinophilic asthma, there are no specific therapies for 40–50% of people with asthma with other phenotypes, which result from poorly understood underlying pathological mechanisms. One such pathology is neutrophilic inflammation, which has...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2020-05-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/6/2/00364-2019.full |